Please login to the form below

Not currently logged in
Email:
Password:

Medivir

This page shows the latest Medivir news and features for those working in and with pharma, biotech and healthcare.

Merck decision to drop odanacatib lifts UCB/Amgen

Merck decision to drop odanacatib lifts UCB/Amgen

Ono Pharmaceutical was also developing a drug in the class called ONO-5334 but pulled the programme in 2012 without giving reasons for the decision, while Medivir discontinued its MIV 701

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • MISSION appoints Paul Wallace as chief business officer MISSION appoints Paul Wallace as chief business officer

    MISSION appoints Paul Wallace as chief business officer. Joins from Medivir where he was executive VP and head of business development. ... During his time at Medivir, he played a key role in the execution of over 25 partnership deals, eight products

  • Medivir names new CEO Medivir names new CEO

    Medivir names new CEO. Niklas Prager has experience at Merck &Co and Pfizer. ... Medivir has named board member Niklas Prager as the company's new CEO replacing Maris Hartmanis.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics